expert roundtables

Insights on the Immunobiology of MDS and AML

by Harry Paul Erba, MD, PhD; Guillermo Garcia-Manero, MD; and David Sallman, MD

Future paradigms for high-risk myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) might involve combinations of targeted therapies and......READ MORE

LATEST IN EXPERT PERSPECTIVES

Browse More Articles